access

The Stanford School of Medicine plans to expand clinical research and healthcare access for historically marginalized and underserved populations, said faculty leaders during Thursday’s Faculty Senate meeting.  While racial minorities represent 40% of the world’s population, 75% of participants in FDA approved clinical trials identified as white in 2020, according […]